Responsible for the management of CVM portfolio brand(Anti-platelet market- Jul’21 & Anti-hypertension market - Jan'20 to present) Responsible for the management of "Tixalor" (new launch of ticagrelor – Anti-Platelet market) and "Candecard Plus" (Anti-Hhypertansive market) (Jan’20 to present) and Preperation of New launch of SGLT-2i & DPP-IV brand(Jan’23 to Jun’23)-Launch anti-platelet brand-Re-Launch anti-hypertensive brand-Preparing product plan, budgets and forecasts based on sales objectives/strategy-KOL management & customer management-Training sales force on specific products and inform about the product updates-Preparing marketing materials in co-operation with advertising, promotion agencies and creative studios-Monitoring the market situation to include major potential customers, trends, developmental opportunities, legislation issues-Attending and organizing educational programs for customers

Responsible for the management of CVM portfolio brand(Anti-platelet market- Jul’21 & Anti-hypertension market - Jan'20 to present)-Launch anti-platelet brand-Re-Launch anti-hypertensive brand-Preparing product plan, budgets and forecasts based on sales objectives/strategy-KOL management & customer management-Training sales force on specific products and inform about the product updates-Preparing marketing materials in co-operation with advertising, promotion agencies and creative studios-Monitoring the market situation to include major potential customers, trends, developmental opportunities, legislation issues-Attending and organizing educational programs for customers

Responsible for the management of CVM portfolio brand(Diabetes market - May'18 to Dec'19)-Preparing marketing plans in accordance with yearly product budgets and strategies-Analyzing products' sales trends with market trends and competitors-Management of products' budgets effectively, organization of congresses, meetings and printed&promotional materials-Communication with 3rd part agencies and customer relations management

Responsible for an inhaler "Foradil Combi Fix", a PPI "Prabex" and a mucolytic "Erdostin"-Focus on specialties; Respiratory, Internal Medicine, Gastroenterology and Pediatrics

-Analyzing physical and chemical characteristics of waste water